首页> 美国卫生研究院文献>British Medical Journal >Design characteristics risk of bias and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency 2014-16: cross sectional analysis

【2h】

Design characteristics risk of bias and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency 2014-16: cross sectional analysis

机译：设计特征偏倚风险以及支持癌症药物获得欧洲药品管理局批准的随机对照试验的报告2014-16年：横截面分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveTo examine the design characteristics, risk of bias, and reporting adequacy of pivotal randomised controlled trials of cancer drugs approved by the European Medicines Agency (EMA).

机译：目的研究欧洲药品管理局（EMA）批准的癌症药物关键性随机对照试验的设计特征，偏倚风险以及报告的充分性。

著录项

期刊名称 British Medical Journal
作者
Huseyin Naci; Courtney Davis; Jelena Savović; Julian P T Higgins; Jonathan A C Sterne; Bishal Gyawali; Xochitl Romo-Sandoval; Nicola Handley; Christopher M Booth;
展开▼
作者单位

展开▼
年(卷),期 2019(366),-1
年度 2019
页码 l5221
总页数 1
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献

1. Response bias to a randomised controlled trial of a lifestyle intervention in people at high risk of cardiovascular disease: a cross-sectional analysis [J] . Adam Bayley, Daniel Stahl, Mark Ashworth, BMC Public Health . 2018,第1期

机译：心血管疾病高风险人群生活方式干预随机对照试验的反应偏倚：横断面分析
2. Comparisons of food and drug administration and European Medicines Agency risk management implementation for recent pharmaceutical approvals: Report of the international society for pharmacoeconomics and outcomes research risk benefit management working group [J] . LisY., RobertsM.H., KambleS., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2012,第8期

机译：食品药品监督管理局与欧洲药品管理局针对最近的药品批准实施风险管理的比较：国际药物经济学和结果研究学会风险收益管理工作组的报告
3. Design analysis indicates Potential overestimation of treatment effects in randomized controlled trials supporting Food and Drug Administration cancer drug approvals [J] . Emily M. Lord, Isabelle R. Weir, Ludovic Trinquart Journal of Clinical Epidemiology . 2018,第期

机译：设计分析表明，随机对照试验中的治疗效果的潜在高估支持食品和药物管理癌症药物批准
4. Fractal Dimension and Lacunarity analysis of mammographicpatterns in assessing breast cancer risk related to HRT treatedpopulation: A Longitudinal and Cross-sectional study [C] . Gopal Karemore, Mads Nielsen SPIE Conference on Medical imaging . 2009

机译：乳房XMPORAPTORNS评估乳腺癌风险与HRT处理相关的分形维图案：纵向和横截面研究
5. Reporting Quality of Randomized Controlled Trials of Periodontal Diseases in Journal Abstracts - A Cross-Sectional Survey and Bibliometric Analysis [D] . Kumar, Satish. 2015

机译：期刊摘要中牙周疾病随机对照试验的报道质量-横断面调查和文献计量分析
6. Does access to clinical study reports from the European Medicines Agency reduce reporting biases? A systematic review and meta-analysis of randomized controlled trials on the effect of erythropoiesis-stimulating agents in cancer patients [O] . Eliane Rohner, Michael Grabik, Thomy Tonia, 2011

机译：从欧洲药品管理局获得临床研究报告是否可以减少报告偏倚？癌症患者促红细胞生成药物作用的随机对照试验的系统评价和荟萃分析
7. Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis [O] . Huseyin Naci, Courtney Davis, Jelena Savović, 2019

机译：设计特征，偏见风险，以及随机对照试验的报告支持欧洲药物局的癌症药物批准，2014-16：横截面分析

Design characteristics risk of bias and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency 2014-16: cross sectional analysis

摘要

著录项

相似文献

相关主题

期刊订阅